How I approach intersectionality in hematopoietic stem cell transplantation

3.

Levesque

JF

,

Harris

MF

,

Russell

G

.

Patient-centred access to health care: conceptualising access at the interface of health systems and populations

.

Int J Equity Health

.

2013

;

12

:

18

.

4.

Sims-Schouten

W

,

Gilbert

P

.

Revisiting ‘resilience’ in light of racism, ‘othering’ and resistance

.

Race Class

.

2022

;

64

(

1

):

84

-

94

.

5.

Johnson

JL

,

Bottorff

JL

,

Browne

AJ

,

Grewal

S

,

Hilton

BA

,

Clarke

H

.

Othering and being othered in the context of health care services

.

Health Commun

.

2004

;

16

(

2

):

255

-

271

.

6.

Boveda

M

,

Annamma

SA

.

Beyond making a statement: an intersectional framing of the power and possibilities of positioning

.

Educ Res

.

2023

;

52

(

5

):

306

-

314

.

7.

Hankivsky

O

,

Doyal

L

,

Einstein

G

, et al.

The odd couple: using biomedical and intersectional approaches to address health inequities

.

Glob Health Action

.

2017

;

10

(

suppl 2

):

1326686

.

8.

Kapilashrami

A

,

Hankivsky

O

.

Intersectionality and why it matters to global health

.

Lancet

.

2018

;

391

(

10140

):

2589

-

2591

.

9.

Samra

R

,

Hankivsky

O

.

Adopting an intersectionality framework to address power and equity in medicine

.

Lancet

.

2021

;

397

(

10277

):

857

-

859

.

10.

Etherington

C

,

Rodrigues

IB

,

Giangregorio

L

, et al.

Applying an intersectionality lens to the theoretical domains framework: a tool for thinking about how intersecting social identities and structures of power influence behaviour

.

BMC Med Res Methodol

.

2020

;

20

(

1

):

169

.

11.

Vanderwoerd

J

.

The promise and perils of anti-oppressive practice for Christians in social work education

.

Soc Work Christianity

.

2016

;

43

(

2

):

153

-

188

.

12.

Center for Teaching LMC

Division for Teaching & Learning

University of Wisconsin-Madison

.

Wheel of privilege and power

. Accessed 1 July 2024. https://kb.wisc.edu/instructional-resources/page.php?id=119380.

13.

Bashey

A

,

Zhang

X

,

Morris

LE

, et al.

Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donors

.

Blood Adv

.

2023

;

7

(

15

):

3816

-

3823

.

14.

Nath

K

,

Lee

J

,

Elko

TA

, et al.

Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia

.

Am J Hematol

.

2023

;

98

(

12

):

1869

-

1876

.

15.

World Health Organization

.

Devastatingly pervasive: 1 in 3 women globally experience violence

. 2021. Accessed 1 July 2024. https://www.who.int/news/item/09-03-2021-devastatingly-pervasive-1-in-3-women-globally-experience-violence.

16.

Raja

S

,

Hasnain

M

,

Hoersch

M

,

Gove-Yin

S

,

Rajagopalan

C

.

Trauma informed care in medicine: current knowledge and future research directions

.

Fam Community Health

.

2015

;

38

(

3

):

216

-

226

.

17.

Bhatnagar

B

,

Eisfeld

AK

.

Racial and ethnic survival disparities in patients with haematological malignancies in the USA: time to stop ignoring the numbers

.

Lancet Haematol

.

2021

;

8

(

12

):

e947

-

e954

.

18.

Bhatnagar

B

,

Kohlschmidt

J

,

Mrozek

K

, et al.

Poor survival and differential impact of genetic features of Black patients with acute myeloid leukemia

.

Cancer Discov

.

2021

;

11

(

3

):

626

-

637

.

19.

Hamed

S

,

Bradby

H

,

Ahlberg

BM

,

Thapar-Bjorkert

S

.

Racism in healthcare: a scoping review

.

BMC Publ Health

.

2022

;

22

(

1

):

988

.

20.

Loree

JM

,

Anand

S

,

Dasari

A

, et al.

Disparity of race reporting and representation in clinical trials leading to cancer drug approvals from 2008 to 2018

.

JAMA Oncol

.

2019

;

5

(

10

):

e191870

.

21.

Tang

C

,

Hamad

N

.

Trials and tribulations: including women in cancer clinical research

.

Lancet Haematol

.

2021

;

8

(

7

):

e477

-

e478

.

22.

Gupta

S

,

Dai

Y

,

Chen

Z

, et al.

Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials

.

Lancet Haematol

.

2023

;

10

(

2

):

e129

-

e141

.

23.

Hamad

N

.

Structural racism in clinical research limits its validity and applicability

.

Lancet Haematol

.

2023

;

10

(

2

):

e85

-

e86

.

24.

Majhail

NS

,

Nayyar

S

,

Santibañez

ME

,

Murphy

EA

,

Denzen

EM

.

Racial disparities in hematopoietic cell transplantation in the United States

.

Bone Marrow Transplant

.

2012

;

47

(

11

):

1385

-

1390

.

25.

Gratwohl

A

,

Baldomero

H

,

Schwendener

A

, et al;

Joint Accreditation Committee of the International Society for Cellular Therapy

European Group for Blood and Marrow Transplantation

European Leukemia Net

.

Predictability of hematopoietic stem cell transplantation rates

.

Haematologica

.

2007

;

92

(

12

):

1679

-

1686

.

26.

Gratwohl

A

,

Schmid

O

,

Baldomero

H

,

Horisberger

B

,

Urbano-Ispizua

A

;

Accreditation Committee of the European Group for Blood and Marrow Transplantation

.

Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey

.

Bone Marrow Transplant

.

2004

;

34

(

10

):

855

-

875

.

27.

Greco-Stewart

V

,

Elmoazzen

H

,

Morris

G

, et al.

Improved access to better HLA-matched hematopoietic cells for allogeneic transplant: analysis of donors and cord blood units selected for Canadian patients in 2018

.

Transfusion

.

2020

;

60

(

7

):

1508

-

1518

.

28.

Mehta

P

,

Pollock

BH

,

Nugent

M

,

Horowitz

M

,

Wingard

JR

.

Access to stem cell transplantation: do women fare as well as men?

.

Am J Hematol

.

2003

;

72

(

2

):

99

-

102

.

29.

Joshua

TV

,

Rizzo

JD

,

Zhang

MJ

, et al.

Access to hematopoietic stem cell transplantation: effect of race and sex

.

Cancer

.

2010

;

116

(

14

):

3469

-

3476

.

30.

Khera

N

,

Deeg

HJ

,

Kodish

E

,

Rondelli

D

,

Majhail

N

.

Allogeneic hematopoietic cell transplantation and other expensive cellular therapies: a miracle for the few but off limits to many?

.

J Clin Oncol

.

2020

;

38

(

12

):

1268

-

1272

.

31.

Khera

N

,

Gooley

T

,

Flowers

MED

, et al.

Association of distance from transplantation center and place of residence on outcomes after allogeneic hematopoietic cell transplantation

.

Biol Blood Marrow Transplant

.

2016

;

22

(

7

):

1319

-

1323

.

32.

Paulson

K

,

Brazauskas

R

,

Khera

N

, et al.

Inferior access to allogeneic transplant in disadvantaged populations: a Center for International Blood and Marrow Transplant Research Analysis

.

Biol Blood Marrow Transplant

.

2019

;

25

(

10

):

2086

-

2090

.

33.

Lane

H

,

Sarkies

M

,

Martin

J

,

Haines

T

.

Equity in healthcare resource allocation decision making: a systematic review

.

Soc Sci Med

.

2017

;

175

:

11

-

27

.

34.

McGowan

VJ

,

Bambra

C

.

COVID-19 mortality and deprivation: pandemic, syndemic, and endemic health inequalities

.

Lancet Public Health

.

2022

;

7

(

11

):

e966

-

e975

.

35.

Dehn

J

,

Chitphakdithai

P

,

Shaw

BE

, et al.

Likelihood of proceeding to allogeneic hematopoietic cell transplantation in the United States after search activation in the national registry: impact of patient age, disease, and search prognosis

.

Transplant Cell Ther

.

2021

;

27

(

2

):

184.e1

-

184.e13

.

36.

Kindwall-Keller

TL

,

Ballen

KK

.

Alternative donor graft sources for adults with hematologic malignancies: a donor for all patients in 2017!

.

Oncologist

.

2017

;

22

(

9

):

1125

-

1134

.

37.

Okamoto

S

,

Iida

M

,

Hamad

N

, et al;

Asia-Pacific Blood and Marrow Transplantation Group APBMT

Australia and New Zealand Transplant and Cellular Therapy ANZTCT

Brazilian Society of Blood and Marrow Transplantation SBTMO

European Society for Blood and Marrow Transplantation EBMT

Indian Society for Blood and Marrow Transplantation ISBMT

Latin America Bone Marrow Transplantation Group LABMT

.

American Society of Transplantation and Cellular Therapy International Affair Committee: report of 3(rd) workshop on global perspective to access to transplantation at the 2022 tandem meeting

.

Transplant Cell Ther

.

2023

;

29

(

7

):

410

-

417

.

38.

Othman

J

,

Aarons

D

,

Bajel

A

, et al.

Allogeneic haematopoietic cell transplant services in Australia and New Zealand in the first year of the COVID-19 pandemic: a report from Australia and New Zealand Transplant and Cellular Therapies

.

Intern Med J

.

2023

;

53

(

3

):

323

-

329

.

39.

Shaw

BE

,

Jimenez-Jimenez

AM

,

Burns

LJ

, et al.

National marrow donor program-sponsored multicenter, phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide

.

J Clin Oncol

.

2021

;

39

(

18

):

1971

-

1982

.

40.

Majhail

NS

,

Omondi

NA

,

Denzen

E

,

Murphy

EA

,

Rizzo

JD

.

Access to hematopoietic cell transplantation in the United States

.

Biol Blood Marrow Transplant

.

2010

;

16

(

8

):

1070

-

1075

.

41.

Hong

S

,

Majhail

NS

.

Increasing access to allotransplants in the United States: the impact of race, geography, and socioeconomics

.

Hematology Am Soc Hematol Educ Program

.

2021

;

2021

(

1

):

275

-

280

.

42.

Sigmund

AM

,

Zhao

Q

,

Jiang

J

, et al.

Impact of race and geographic area of residence on outcomes after allogeneic stem cell transplant

.

Front Oncol

.

2022

;

12

:

801879

.

43.

Weyand

AC

,

McGann

PT

.

Eliminating race-based reference ranges in haematology: a call to action

.

Lancet Haematol

.

2021

;

8

(

6

):

e462

-

e466

.

44.

Vyas

DA

,

Eisenstein

LG

,

Jones

DS

.

Hidden in plain sight - reconsidering the use of race correction in clinical algorithms

.

N Engl J Med

.

2020

;

383

(

9

):

874

-

882

.

45.

Sorror

ML

,

Maris

MB

,

Storb

R

, et al.

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

.

Blood

.

2005

;

106

(

8

):

2912

-

2919

.

46.

Thakar

MS

,

Broglie

L

,

Logan

B

, et al.

The hematopoietic cell transplant comorbidity index predicts survival after allogeneic transplant for nonmalignant diseases

.

Blood

.

2019

;

133

(

7

):

754

-

762

.

47.

ElSawy

M

,

Storer

BE

,

Pulsipher

MA

, et al.

Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation

.

Br J Haematol

.

2015

;

170

(

4

):

574

-

583

.

48.

Figueroa Turienzo

CM

,

Cernadas

C

,

Roizen

M

,

Pizzi

S

,

Staciuk

R

.

Validation of the hematopoietic cell transplantation-specific comorbidity index in a retrospective cohort of children and adolescents who received an allogeneic transplantation in Argentina

.

Arch Argent Pediatr

.

2016

;

114

(

4

):

337

-

342

.

49.

Nakaya

A

,

Mori

T

,

Tanaka

M

, et al.

Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for cell therapy

.

Biol Blood Marrow Transplant

.

2014

;

20

(

10

):

1553

-

1559

.

50.

Sorror

ML

,

Logan

BR

,

Zhu

X

, et al.

Prospective validation of the predictive power of the hematopoietic cell transplantation comorbidity index: a Center for International Blood and Marrow Transplant Research Study

.

Biol Blood Marrow Transplant

.

2015

;

21

(

8

):

1479

-

1487

.

51.

Veeraputhiran

M

,

Yang

L

,

Sundaram

V

, et al.

Validation of the hematopoietic cell transplantation-specific comorbidity index in nonmyeloablative allogeneic stem cell transplantation

.

Biol Blood Marrow Transplant

.

2017

;

23

(

10

):

1744

-

1748

.

52.

Humphreys

S

.

The unethical use of BMI in contemporary general practice

.

Br J Gen Pract

.

2010

;

60

(

578

):

696

-

697

.

53.

Hood

K

,

Ashcraft

J

,

Watts

K

, et al.

Allometric scaling of weight to height and resulting body mass index thresholds in two Asian populations

.

Nutr Diabetes

.

2019

;

9

(

1

):

2

.

54.

Moharram

MA

,

Aitken-Buck

HM

,

Reijers

R

, et al.

Correlation between epicardial adipose tissue and body mass index in New Zealand ethnic populations

.

N Z Med J

.

2020

;

133

(

1516

):

22

-

32

.

55.

Fontaine

KR

,

Redden

DT

,

Wang

C

,

Westfall

AO

,

Allison

DB

.

Years of life lost due to obesity

.

JAMA

.

2003

;

289

(

2

):

187

-

193

.

56.

Baker

RE

,

Mahmud

AS

,

Miller

IF

, et al.

Infectious disease in an era of global change

.

Nat Rev Microbiol

.

2022

;

20

(

4

):

193

-

205

.

57.

National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer stat facts: cancer disparities

. Accessed 1 July 2024. https://seer.cancer.gov/statfacts/html/disparities.html.

58.

Armand

P

,

Kim

HT

,

Logan

BR

, et al.

Validation and refinement of the disease risk index for allogeneic stem cell transplantation

.

Blood

.

2014

;

123

(

23

):

3664

-

3671

.

59.

Penney

TL

,

Kirk

SF

.

The health at every size paradigm and obesity: missing empirical evidence may help push the reframing obesity debate forward

.

Am J Public Health

.

2015

;

105

(

5

):

e38

-

e42

.

60.

Cénat

JM

.

Complex racial trauma: evidence, theory, assessment, and treatment

.

Perspect Psychol Sci

.

2023

;

18

(

3

):

675

-

687

.

61.

Kanda

J

,

Brazauskas

R

,

Hu

ZH

, et al.

Graft-versus-host disease after HLA-matched sibling bone marrow or peripheral blood stem cell transplantation: comparison of North American Caucasian and Japanese populations

.

Biol Blood Marrow Transplant

.

2016

;

22

(

4

):

744

-

751

.

62.

Morishima

Y

,

Kawase

T

,

Malkki

M

, et al;

International Histocompatibility Working Group in Hematopoietic Cell Transplantation

.

Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation

.

Biol Blood Marrow Transplant

.

2013

;

19

(

8

):

1197

-

1203

.

63.

Morishima

S

,

Ogawa

S

,

Matsubara

A

, et al;

Japan Marrow Donor Program

.

Impact of highly conserved HLA haplotype on acute graft-versus-host disease

.

Blood

.

2010

;

115

(

23

):

4664

-

4670

.

64.

Warren

EH

,

Zhang

XC

,

Li

S

, et al.

Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT

.

Blood

.

2012

;

120

(

14

):

2796

-

2806

.

65.

Martin

PJ

,

Levine

DM

,

Storer

BE

, et al.

Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease

.

Blood

.

2017

;

129

(

6

):

791

-

798

.

66.

Inamoto

Y

,

White

J

,

Ito

R

, et al.

Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients

.

Blood Adv

.

2019

;

3

(

18

):

2764

-

2777

.

67.

Lester

JC

,

Taylor

SC

,

Chren

MM

.

Under-representation of skin of colour in dermatology images: not just an educational issue

.

Br J Dermatol

.

2019

;

180

(

6

):

1521

-

1522

.

68.

Guo

LN

,

Lee

MS

,

Kassamali

B

,

Mita

C

,

Nambudiri

VE

.

Bias in, bias out: underreporting and underrepresentation of diverse skin types in machine learning research for skin cancer detection - a scoping review

.

J Am Acad Dermatol

.

2022

;

87

(

1

):

157

-

159

.

69.

Zeiser

R

,

von Bubnoff

N

,

Butler

J

, et al;

REACH2 Trial Group

.

Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease

.

N Engl J Med

.

2020

;

382

(

19

):

1800

-

1810

.

70.

Zeiser

R

,

Polverelli

N

,

Ram

R

, et al;

REACH3 Investigators

.

Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease

.

N Engl J Med

.

2021

;

385

(

3

):

228

-

238

.

71.

Mielcarek

M

,

Gooley

T

,

Martin

PJ

, et al.

Effects of race on survival after stem cell transplantation

.

Biol Blood Marrow Transplant

.

2005

;

11

(

3

):

231

-

239

.

72.

Perram

J

,

Schoemans

H

,

Hamad

N

.

First, do no harm: the neglect of female genital disease following haematopoietic stem-cell transplantation

.

Lancet Haematol

.

2022

;

9

(

7

):

e476

-

e477

.

73.

Rotz

SJ

,

Bhatt

NS

,

Hamilton

BK

, et al.

International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update

.

Bone Marrow Transplant

.

2024

;

59

(

6

):

717

-

741

.